Africa CDC director blames lack of interest for absence of Bundibugyo Ebola vaccine

Dr Jean Kaseya said the Bundibugyo strain has no approved vaccine because partners treated it as an African issue.

Africa CDC director blames lack of interest for absence of Bundibugyo Ebola vaccine
Photo: Premium Times Nigeria

The Director-General of the Africa Centres for Disease Control and Prevention, Dr Jean Kaseya, has blamed a lack of international interest for the absence of an approved vaccine for the Bundibugyo strain of Ebola. He said that if the outbreak were in Western countries, a vaccine would already be available.

Kaseya said some partners decided to consider the issue as an African issue and were not interested. He argued the strain received less attention because it has caused only three outbreaks since it was first identified in Uganda 19 years ago, compared to the Zaire strain which has been responsible for more than 16 outbreaks.

The Africa CDC is taking a more active role to address the gap by initiating clinical trials of new vaccine candidates. An African manufacturer in Egypt is currently conducting clinical trials of a potential vaccine against the Bundibugyo strain.

The agency is also working with Uganda and the Democratic Republic of the Congo to make Ervebo, a vaccine developed for the Zaire strain, available for compassionate use and clinical trials. Kaseya said the current outbreak should lead to lasting changes, including increased local vaccine manufacturing and better coordination among international partners.

Nigeria confirmed its first imported case of Bundibugyo Ebola in the Federal Capital Territory on October 20. The patient, a woman who recently travelled from Uganda, was receiving medical care while health authorities identified 44 contacts for monitoring.

Key facts

  • The Bundibugyo strain of Ebola was first identified in Uganda 19 years ago.
  • An African manufacturer in Egypt is conducting clinical trials for a potential Bundibugyo vaccine.
  • Nigeria confirmed its first imported case of Bundibugyo Ebola on October 20.

Three perspectives

Neutral

The Africa CDC is working with Uganda and the Democratic Republic of the Congo to make the Zaire strain vaccine, Ervebo, available for clinical trials and compassionate use.

Positive

Twenty-eight African countries have contributed funds to support the response, which Kaseya described as a sign of changing attitudes towards financing the continent's health emergencies.

Negative

Kaseya stated that the Bundibugyo strain has no approved vaccine because some partners considered it an African issue and lacked interest.

Your week in news, every Wednesday

The biggest stories of the week for your edition, in your inbox every Wednesday morning, your time. Free, and you can unsubscribe at any time.

Choose your news coverage

Please choose and confirm your coverage.

Ebola outbreak in DRC remains uncontrolled after six months
Next storyEbola outbreak in DRC remains uncontrolled after six months

All sections

Edition